SCHEMBL19861446

SCHEMBL19861446

CCCCCCC(C)(C)CCCC(=O)OCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.53
PAM P19021 2/20 0.49
CYP1A2 P05177 1/20 0.48
MAPT P10636 2/20 0.46
TSHR P16473 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
LMNA P02545 4/20 0.45
DNM1 Q05193 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KDM4E B2RXH2 1/20 0.44
DUSP3 P51452 1/20 0.44
GAA P10253 1/20 0.43
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
PRKCA P17252 1/20 0.41
PRKCE Q02156 1/20 0.41
PRKCQ Q04759 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19861519 0.93 DGKA (0.48) DGKAPAMCYP1A2MAPTTSHR
SCHEMBL21015257 0.89 CYP1A2 (0.52) DGKAPAMCYP1A2MAPTTSHR
SCHEMBL20076474 0.86 DGKA (0.50) DGKAPAMCYP1A2MAPTTSHR
SCHEMBL19861329 0.84 FFAR1 (0.48) DGKAMAPTMEN1KMT2AATM
SCHEMBL12504468 0.84 DGKA (0.46) DGKAPAMMAPTTSHRLMNA
SCHEMBL12504384 0.84 DGKA (0.46) DGKAPAMMAPTTSHRLMNA
SCHEMBL12504194 0.84 DGKA (0.46) DGKAPAMMAPTTSHRLMNA
SCHEMBL21015892 0.84 TSHR (0.50) DGKAPAMMAPTTSHRLMNA
SCHEMBL20457453 0.84 FFAR1 (0.48) DGKAMAPTMEN1KMT2AATM
SCHEMBL19861337 0.84 CYP1A2 (0.50) DGKAPAMCYP1A2MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647747-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2020-05-12 US disclosed
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. 2018-04-19 US disclosed
US-9890198-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2018-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647747-B2 Cyclosporin derivatives and uses thereof FKBP5, FKBP1B, MALT1 DGKA 4006/4885PAM 4885/4885CYP1A2 805/4885
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 DGKA 4049/4885PAM 4885/4885CYP1A2 1223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.